209 related articles for article (PubMed ID: 28401451)
1. COL1A2 is a Novel Biomarker to Improve Clinical Prediction in Human Gastric Cancer: Integrating Bioinformatics and Meta-Analysis.
Rong L; Huang W; Tian S; Chi X; Zhao P; Liu F
Pathol Oncol Res; 2018 Jan; 24(1):129-134. PubMed ID: 28401451
[TBL] [Abstract][Full Text] [Related]
2. Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer.
Xu J; Wang X; Ke Q; Liao K; Wan Y; Zhang K; Zhang G; Wang X
Sci Rep; 2021 Jul; 11(1):15412. PubMed ID: 34326374
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
[TBL] [Abstract][Full Text] [Related]
4. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Xing W; Zeng C
Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
[TBL] [Abstract][Full Text] [Related]
5. Amplified 7q21-22 gene MCM7 and its intronic miR-25 suppress COL1A2 associated genes to sustain intestinal gastric cancer features.
Tamilzhalagan S; Rathinam D; Ganesan K
Mol Carcinog; 2017 Jun; 56(6):1590-1602. PubMed ID: 28059478
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
7. Elevated THBS2, COL1A2, and SPP1 Expression Levels as Predictors of Gastric Cancer Prognosis.
Zhuo C; Li X; Zhuang H; Tian S; Cui H; Jiang R; Liu C; Tao R; Lin X
Cell Physiol Biochem; 2016; 40(6):1316-1324. PubMed ID: 27997896
[TBL] [Abstract][Full Text] [Related]
8. Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer.
Li J; Ding Y; Li A
World J Surg Oncol; 2016 Nov; 14(1):297. PubMed ID: 27894325
[TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods.
Nie K; Shi L; Wen Y; Pan J; Li P; Zheng Z; Liu F
Minerva Med; 2020 Jun; 111(3):213-225. PubMed ID: 31638362
[TBL] [Abstract][Full Text] [Related]
10. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
[TBL] [Abstract][Full Text] [Related]
11. GCGene: a gene resource for gastric cancer with literature evidence.
Zhao M; Chen L; Liu Y; Qu H
Oncotarget; 2016 Jun; 7(23):33983-93. PubMed ID: 27127885
[TBL] [Abstract][Full Text] [Related]
12. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
[TBL] [Abstract][Full Text] [Related]
13. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H
Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics insight into glycosyltransferase gene expression in gastric cancer: POFUT1 is a potential biomarker.
Dong S; Wang Z; Huang B; Zhang J; Ge Y; Fan Q; Wang Z
Biochem Biophys Res Commun; 2017 Jan; 483(1):171-177. PubMed ID: 28040433
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
17. Juxtaposed genes in 7q21-22 amplicon contribute for two major gastric cancer sub-Types by mutual exclusive expression.
Tamilzhalagan S; Muthuswami M; Ganesan K
Mol Carcinog; 2017 Apr; 56(4):1239-1250. PubMed ID: 27805295
[TBL] [Abstract][Full Text] [Related]
18. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications.
Yasui W; Oue N; Ito R; Kuraoka K; Nakayama H
Cancer Sci; 2004 May; 95(5):385-92. PubMed ID: 15132764
[TBL] [Abstract][Full Text] [Related]
19. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.
Zhou L; Li SH; Wu Y; Xin L
Cancer Med; 2021 May; 10(10):3309-3322. PubMed ID: 33934516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
